At this year's Shanghai Auto Show, FAW-Volkswagen has brought a great gift for fans who love "big guys"—the all-new mid- to ...
Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.
MapLight Therapeutics is a clinical-stage biopharma focused on CNS disorders and has filed for a $100M U.S. IPO to fund its ...
ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...
Detailed price information for Roche Holdings Ltd ADR (RHHBY) from The Globe and Mail including charting and trades.
Objective Youth with childhood-onset SLE (cSLE) have increased risk of serious infection. It is unknown how much of this risk ...
This article was originally published by Uncloseted Media.By Spencer MacNaughton, Sam Donndelinger, Taya StraussIn the United ...
SKNY transaction strengthens MIRA pipeline with SKNY-1, a differentiated oral candidate that has demonstrated up to 30% ...
Over the last three decades, the evidence on how to best treat the cognitive and non-cognitive symptoms of patients with ...
A perfectly preserved dinosaur embryo has been found in China: little Yingliang reveals the posture of birds before birth.
In this article, ACRO explores multiple sclerosis—a silent battle unfolding within the central nervous system.
Is nearing full enrollment for its NEO100-01 Phase 2a trial, with top-line data readout anticipated in early 2026. The final patient cohort in its NEO212 Phase I trial is also on track for completion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results